ImmunityBio Inc

14 Sept 2026, 20:08 UTC

ImmunityBio Inc is gaining as it participates in key cancer conferences this week and files a patent for Anktiva to enhance immune response.

11 Sept 2026, 20:03 UTC

ImmunityBio Inc is higher as it prepares for key presentations at upcoming conferences and highlights potential uses for Anktiva in cancer treatment.

10 Sept 2026, 19:36 UTC

ImmunityBio shares are lower as Bronstein, Gewirtz & Grossman, LLC announces an investigation into potential corporate wrongdoing targeting prior investors.

9 Sept 2026, 23:01 UTC

Immunitybio Inc. shares declined after hours, reflecting a notable drop from an earlier session high amid no specific company news identified.

8 Sept 2026, 23:16 UTC

Immunitybio Inc shares are lower in after-market hours, with no specific news identified. Broader market weakness is attributed to geopolitical tensions in the Middle East.

3 Sept 2026, 19:26 UTC

Immunitybio Inc's shares are higher today, reflecting positive market sentiment amid declining Treasury yields and easing labor market concerns.

2 Sept 2026, 23:06 UTC

Immunitybio Inc shares are lower in after-market trading, with no specific news identified. The broader market reacted to a weaker ADP payrolls report.

31 Aug 2026, 20:07 UTC

Immunitybio Inc shares are lower amid broader market pressures and rising bond yields following comments from Warsh at the Jackson Hole Economic Symposium.

29 Aug 2026, 00:01 UTC

Immunitybio Inc shares are higher in after-market trading, though no specific news was identified for the price movement. The stock remains near its one-month range high.

28 Aug 2026, 20:02 UTC

Immunitybio Inc. shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields. The stock remains above its 20-day moving average.

27 Aug 2026, 23:01 UTC

Immunitybio Inc. traded roughly flat after-market, despite earlier gains. Broader market trends reflected mixed trading and inflation concerns ahead of a key Fed speech.

26 Aug 2026, 19:16 UTC

ImmunityBio Inc. shares are trading higher as institutional interest grows, with Virginia Retirement System holding 74,500 shares and promising trial data for Anktiva.

24 Aug 2026, 20:06 UTC

Immunitybio Inc's shares are lower today, continuing a decline over three trading days. Broader market sentiment is impacted by rising oil prices and geopolitical tensions.

21 Aug 2026, 19:16 UTC

Immunitybio Inc. shares are lower today amid rising crude oil prices and geopolitical tensions, despite remaining above their 20-day moving average.

20 Aug 2026, 23:06 UTC

Immunitybio Inc. shares are lower in after-market trading, declining since Thursday's close. The asset remains above its 20-day moving average.

19 Aug 2026, 19:26 UTC

Immunitybio Inc shares are higher Wednesday, buoyed by social media discussions anticipating prices between $8 and $12. The stock remains above its 20-day moving average.

18 Aug 2026, 23:06 UTC

Immunitybio Inc shares are lower in after-market hours, with no specific news identified. Broader market conditions reflect a decline in U.S. stocks.

14 Aug 2026, 19:36 UTC

Immunitybio shares are lower amid broader market sentiment following a reported decline in retail sales, raising concerns about consumer demand and economic health.

10 Aug 2026, 19:16 UTC

ImmunityBio Inc. appoints Dr. Jim Yong Kim as Vice Chairman. Shares are lower today amid broader market pressure from a U.S. jobs report.

7 Aug 2026, 23:06 UTC

Immunitybio Inc's shares are lower in after-market hours, with no specific news driving the decline. The stock remains above its 20-day moving average.

6 Aug 2026, 23:11 UTC

Immunitybio Inc's shares are higher in after-market trading, reflecting a slight increase since Thursday's close, though still below the 20-day moving average.

5 Aug 2026, 19:26 UTC

Immunitybio Inc's shares are higher today amid positive market sentiment. The stock is recovering from earlier weakness despite remaining below its 20-day moving average.

4 Aug 2026, 23:46 UTC

Immunitybio Inc. shares are trading roughly flat in after-market hours. The asset remains significantly below its 20-day moving average.

3 Aug 2026, 23:21 UTC

Immunitybio Inc shares rose in after-market trading, settling higher since Monday's close. The stock remains below its 20-day moving average.

1 Aug 2026, 00:02 UTC

Immunitybio Inc shares are higher in after-market trading, reflecting a notable increase since Friday's close amid broader market dynamics.

31 Jul 2026, 23:06 UTC

Immunitybio Inc's shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

30 Jul 2026, 19:29 UTC

Immunitybio Inc is trading higher, recovering from an earlier drop. The stock has rebounded significantly since Wednesday's close, despite six consecutive lower daily closes.

29 Jul 2026, 23:41 UTC

ImmunityBio receives UAE marketing authorization for ANKTIVA®, expanding its reach to 34 countries. Shares are trading higher in after-market hours following the announcement.

28 Jul 2026, 20:06 UTC

ImmunityBio Inc is under investigation for potential wrongdoing, contributing to its decline today. Shares remain lower since Monday's close, marking six consecutive sessions of losses.

27 Jul 2026, 19:16 UTC

Immunitybio Inc. shares are lower, continuing a four-session decline amid broader market pressures and a significant drop in oil prices.